Showing results (551-560 of 844) with videos related to

Sort By:
Pageof 85
Lancet (London, England)|February 12, 1994
Effect of systemic adjuvant treatment on first sites of breast cancer relapseA Goldhirsch, R D Gelber, K N Price, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 1994
The International (Ludwig) Breast Cancer Study Group Trials I-IV: 15 years follow-upM Castiglione-Gertsch, C Johnsen, A Goldhirsch, et al.
Israel Journal of Medical Sciences|February 1, 1995
The best available adjuvant treatments are within the framework of clinical trials. The International Breast Cancer Study GroupA Goldhirsch, R D Gelber, M Castiglione, et al.
Breast (Edinburgh, Scotland)|November 4, 2009
Metronomic administration of pegylated liposomal-doxorubicin in extensively pre-treated metastatic breast cancer patients: a mono-institutional case-series reportE Munzone, A Di Pietro, A Goldhirsch, et al.
Breast (Edinburgh, Scotland)|August 21, 2013
Randomized phase II study of sunitinib versus standard of care for patients with previously treated advanced triple-negative breast cancerGiuseppe Curigliano, Xavier Pivot, Javer Cortés, et al.
Cancer Chemotherapy and Pharmacology|December 8, 2007
Tailored preoperative treatment of locally advanced triple negative (hormone receptor negative and HER2 negative) breast cancer with epirubicin, cisplatin, and infusional fluorouracil followed by weekly paclitaxelRosalba Torrisi, Alessandra Balduzzi, Raffaella Ghisini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 19, 2012
Prognosis of medullary breast cancer: analysis of 13 International Breast Cancer Study Group (IBCSG) trialsJ Huober, S Gelber, A Goldhirsch, et al.
Cellular Signalling|March 10, 2015
Association of p75(NTR) and α9β1 integrin modulates NGF-dependent cellular responsesErin M Ventresca, Shimon Lecht, Piotr Jakubowski, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 8, 2005
Stretched exponential decay and correlations in the catalytic activity of fluctuating single lipase moleculesOphir Flomenbom, Kelly Velonia, Davey Loos, et al.
Breast Cancer Research and Treatment|January 30, 2007
Fulvestrant in heavily pre-treated patients with advanced breast cancer: results from a single compassionate use programme centreChiara Catania, Gilda Ascione, Laura Adamoli, et al.
Pageof 85